Health-Economic Comparison of a Gnrh-Antagonist (Degarelix) Vs. Gnrh-Agonists Considering the Number-Needed-to-Treat to Avoid Cardiovascular Events
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1145
https://www.valueinhealthjournal.com/article/S1098-3015(15)03221-0/fulltext
Title :
Health-Economic Comparison of a Gnrh-Antagonist (Degarelix) Vs. Gnrh-Agonists Considering the Number-Needed-to-Treat to Avoid Cardiovascular Events
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)03221-0&doi=10.1016/j.jval.2015.09.1145
First page :
A452
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
645